Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease
AssigneesCordis Corporation, Wyeth
InventorsRobert Falotico, Jonathan Zhao
Life of this patent
Estimating the term…
Loading patent…
AssigneesCordis Corporation, Wyeth
InventorsRobert Falotico, Jonathan Zhao
Estimating the term…
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots.
A medical device comprising:
Dependencies are inferred from the claim text.